logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Huaxia Wealth Management was fined 12 million yuan for improper investment operations and other irregularities.

date
12/09/2025
On September 12, the list of administrative penalties disclosed by the China Banking and Insurance Regulatory Commission showed that due to improper investment operations, inadequate system control, and non-compliance with regulatory data reporting, Huaxia Wealth Management Co., Ltd. was fined 12 million yuan, while Wang Tao and Zhang Zhitao were warned and fined a total of 100,000 yuan.
Latest
3 m ago
Huatai Securities (06886.HK) plans to issue corporate bonds not exceeding 6 billion yuan.
3 m ago
CEO of Tether Paul Adalinno stated that the company will launch a US domestic stablecoin called USAT.
4 m ago
As of the closing at 23:00, most domestic futures main contracts increased. Fuel oil, coke, and coking coal rose by more than 2%, low-sulfur fuel oil, and liquefied petroleum gas rose by more than 1%. In terms of declines, rapeseed meal fell by more than 1%.
5 m ago
Dollar bond movement | EHICAR 7 09/21/26 has decreased by 6.107% to 68.750.
5 m ago
Biotechnology company Avidity Biosciences rose 6.7% in early trading, after the company announced the pricing of a $600 million stock offering to advance its clinical projects and expand its commercial infrastructure. The funds raised will be used to support the development of its AOC platform and potential product launches, laying the foundation for the company's future growth.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.